- Home
- ATAI
as of 01-22-2026 11:08am EST
$4.04
+$0.12
+2.93%
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | AMSTELVEEN |
| Market Cap: | 1.4B | IPO Year: | 2021 |
| Target Price: | $13.86 | AVG Volume (30 days): | 4.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.15 - $6.75 | Next Earning Date: | 11-12-2025 |
| Revenue: | $3,018,000 | Revenue Growth: | 811.78% |
| Revenue Growth (this year): | 962.66% | Revenue Growth (next year): | -94.11% |
Latest ATAI Life Sciences N.V. News
ATAI Breaking Stock News: Dive into ATAI Ticker-Specific Updates for Smart Investing
MT Newswires
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading
📊
AI Sentiment
Positive
6/10
GlobeNewswire
Aluminum Fishing Boats Market Analysis 2026-2032: Surge in Online Sales Channels and Technological Advancements
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Defying the Standard: JumpCloud Acclaimed for Its Authentic Work Culture
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Oconee Federal Financial Corp. Announces Quarterly Dividend
📈
AI Sentiment
Highly Positive
8/10
TheStreet
This airline to be first in North America to fly direct to this Japanese city
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Kawa Capital Ditches Entire $6.5 Million Stake in Delek, According to Recent SEC Filing
📉
AI Sentiment
Negative
3/10
GlobeNewswire
Global Wood Bio-Products Market to Surpass USD 787 Billion by 2035
📈
AI Sentiment
Highly Positive
9/10
Compare ATAI vs Leading Stocks
See how ATAI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ATAI ATAI Life Sciences N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.